Domov › Obézita › Indiana › Indianapolis
Klinické štúdie Obézita v meste Indianapolis, IN
20 štúdií pre Obézita hľadá účastníkov v zariadeniach v meste Indianapolis a okolí (do cca 30 míľ). Otvorte štúdiu a zistite, kto sa môže zapojiť a ako kontaktovať tím.
Oficiálny text štúdie (anglicky)
Hľadáte účastníkov do štúdie? Zvýraznite ju na začiatku tejto stránky – $99 na 30 dní →
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Prebieha náborFáza 2
- Franciscan Physician Network - Indiana Heart Physicians, Indianapolis
A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight
Prebieha náborFáza 3
- IU Health - Riley Physicians Endo-Diab, Indianapolis
AMAZE 9: A Research Study Investigating How Well Zenagamtide Tablets Help People With Excess Body Weight Lose Weight
Prebieha náborFáza 3
- Midwest Inst For Clin Res, Indianapolis
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
Prebieha náborFáza 3
- Midwest Inst For Clin Res, Indianapolis
Mirikizumab and Tirzepatide Administered in Adult Participants With Moderately to Severely Active Crohn's Disease and Obesity or Overweight
Prebieha náborFáza 3
- Indiana University Health University Hospital, Indianapolis
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
Prebieha náborFáza 3
- Riley Hospital for Children, Indianapolis
Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study
Prebieha náborFáza 3
- Indiana University Health University Hospital, Indianapolis
AMAZE 1: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight Lose Weight
Prebieha náborFáza 3
- Midwest Inst For Clin Res, Indianapolis
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Prebieha náborFáza 3
- DM Clinical Research - Indianapolis, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
Prebieha náborFáza 3
- AURORA-1 Clinical Site, Indianapolis
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
Prebieha náborFáza 3
- AURORA-2 Clinical Site, Indianapolis
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
Prebieha náborFáza 3
- Ascension Medical Group, Indianapolis
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Prebieha náborFáza 2
- Investigators Research Group, Brownsburg · 14 míľ odtiaľ
A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Prebieha náborFáza 4
- Dawes Fretzin Clinical Research Group, LLC, Indianapolis
- The Indiana Clinical Trials Center, PC, Plainfield · 14 míľ odtiaľ
A Research Study to Compare Two Different Versions of Injectable Cagrilintide and Placebo in People With Excess Body Weight
Prebieha náborFáza 3
- Midwest Inst For Clin Res, Indianapolis
The Gut Microbiome in Type 1 Diabetes and Mechanism of Metformin Action
Prebieha náborFáza 2
- Indiana University School of Medicine, Indianapolis
A Research Study to Look at How Well NNC0487-0111 Works Compared to Placebo in People With Heart Failure and Obesity
Prebieha náborFáza 3
- Indiana University Health Methodist Hospital, Indianapolis
A Sensory Strategy to Cut Sugary Beverages in African/American and Latine Adolescents
Prebieha náborVítaní zdravých dobrovoľníkov
- Indiana University Hospital, Indianapolis
Fibrosis Lessens After Metabolic Surgery
Prebieha náborFáza 4Vítaní zdravých dobrovoľníkov
- Indiana University, Indianapolis
Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes
Prebieha nábor
- Indiana University, Indianapolis
Štúdie Obézita v iných mestách
- Houston, TX43 štúdií
- Chicago, IL41 štúdií
- New York City, NY40 štúdií
- San Antonio, TX40 štúdií
- Washington, DC33 štúdií
- Orlando, FL31 štúdií
- Dallas, TX30 štúdií
- Boston, MA28 štúdií
- Las Vegas, NV27 štúdií
- Miami, FL27 štúdií
- Baltimore, MD25 štúdií
- Jacksonville, FL25 štúdií
Iné štúdie v Indianapolis
- Nemalobunkový karcinóm pľúc32 štúdií
- Rakovina (všetky typy)24 štúdií
- Srdcové zlyhanie23 štúdií
- Rakovina prsníka20 štúdií
- Metastatická rakovina19 štúdií
- Kolorektálny karcinóm18 štúdií
- Rakovina vaječníkov17 štúdií
- Rakovina pľúc16 štúdií
- Kardiovaskulárne ochorenia16 štúdií
- Diabetes mellitus 1. typu14 štúdií
- Rakovina endometria14 štúdií
- Alzheimerova choroba14 štúdií
Z ClinicalTrials.gov, dáta načítané 5. 10. 2026. Každá štúdia má vlastné kritériá oprávnenosti; tím štúdie rozhoduje o účasti.